The Food and Drug Administration (FDA or we) is reopening the comment period for the notice titled "Butylated Hydroxytoluene (BHT); Request for Information," which published in the Federal Register of May 13, 2026. We are taking this action in response to a request from stakeholders to extend the comment period to allow additional time for interested parties to develop and submit data, other information, and comments for this request for information.
US Federal Register - FDA Notices · July 30, 2026
Butylated Hydroxytoluene (BHT); Request for Information; Reopening of Comment Period
FDA reopens comment period for BHT safety and regulatory information request to allow stakeholders additional time for data submission.
Published by US Federal Register - FDA Notices. HealthSignal links to the original document; the summary above is extracted from the source text.